Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 170
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04829383 | A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma | ||
| NCT01407562 | Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors | ||
| NCT00176605 | Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer | ||
| NCT05373823 | MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors | ||
| NCT01009931 | Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies | ||
| NCT00176488 | Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | ||
| NCT02315196 | Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer | ||
| NCT04929899 | Bright Ideas - CIN Feasibility Study | ||
| NCT00946283 | Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome | ||
| NCT00578240 | Molecular Studies and Clinical Correlations in Human Prostatic Disease | ||
| NCT00934895 | Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca | ||
| NCT02202044 | Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection | ||
| NCT03112668 | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners | ||
| NCT02620527 | Concordance Between ctDNA Assay and FoundationOne | ||
| NCT04211259 | Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization | ||
| NCT05296421 | Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer | ||
| NCT05736367 | Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer | ||
| NCT02621398 | Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer | ||
| NCT00899808 | Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer | ||
| NCT04253483 | Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer | ||
| NCT00866840 | Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery | ||
| NCT02748564 | Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma | ||
| NCT00176475 | Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease | ||
| NCT00251186 | First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients | ||
| NCT01711944 | Online Problem Solving Skills Training | ||
| NCT02295540 | Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity | ||
| NCT04713449 | Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial | ||
| NCT06073626 | Addressing Genomic Disparities in Cancer Survivors | ||
| NCT01510119 | Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma | ||
| NCT02688192 | Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors | ||
| NCT00176540 | Dextromethorphan in Treating Patients With Fatigue Caused by Cancer | ||
| NCT06763770 | Digital Self-Management and Peer Mentoring Intervention | ||
| NCT00939380 | Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial | ||
| NCT02699983 | eHealth Weight Loss Program in African American Breast Cancer Survivors | ||
| NCT00765765 | Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer | ||
| NCT02421575 | Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance | ||
| NCT00138151 | Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer | ||
| NCT04839588 | Telerehabilitation Cognitive Impairments Following Chemotherapy Usability Study | ||
| NCT01694589 | A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer | ||
| NCT04285268 | Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma | ||
| NCT02177838 | Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer | ||
| NCT00004058 | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder | ||
| NCT03102060 | Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant | ||
| NCT02699996 | Peer Mentoring in Promoting Follow-up Care Self-Management in Younger Childhood Cancer Survivors | ||
| NCT00118053 | Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer | ||
| NCT00878657 | Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer | ||
| NCT04081688 | Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC | ||
| NCT00891969 | Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions | ||
| NCT02015104 | Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG | ||
| NCT04972019 | Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study |
